{"id":91142,"date":"2026-09-23T14:33:50","date_gmt":"2026-09-23T09:03:50","guid":{"rendered":"https:\/\/newswireindia.in\/index.php\/2026\/09\/23\/lords-mark-industries-gets-nod-for-final-clinical-trials-of-ai-breast-cancer-screening-device\/"},"modified":"2026-09-23T14:33:50","modified_gmt":"2026-09-23T09:03:50","slug":"lords-mark-industries-gets-nod-for-final-clinical-trials-of-ai-breast-cancer-screening-device","status":"publish","type":"post","link":"https:\/\/newswireindia.in\/index.php\/2026\/09\/23\/lords-mark-industries-gets-nod-for-final-clinical-trials-of-ai-breast-cancer-screening-device\/","title":{"rendered":"Lord\u2019s Mark Industries Gets Nod for Final Clinical Trials of AI Breast Cancer Screening Device"},"content":{"rendered":"<div>\n<p class=\"wp-block-paragraph\"><strong>New Delhi [India], September 23:<\/strong> Lord\u2019s Mark Industries Limited has informed the BSE that its <strong>Technical Committee has approved the final clinical trial stage for its AI-powered, radiation-free wearable breast cancer screening device<\/strong>, with trials planned across the <strong>USA, Great Britain and Europe<\/strong>. The disclosure was made under <strong>Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015<\/strong>.<\/p>\n<p class=\"wp-block-paragraph\">The device, developed in collaboration with the <strong>Centre for Materials for Electronic Technology (C-MET)<\/strong>, uses <strong>thermal sensors and AI-based temperature mapping<\/strong> to identify abnormalities without radiation. According to the company, clinical trials in India have been completed, with <strong>Phase 2 trials targeting cell-level detection accuracy of 98% set to begin from January 2027 across India, the USA, Europe and Great Britain<\/strong>.<\/p>\n<p class=\"wp-block-paragraph\">Lord\u2019s Mark holds <strong>exclusive commercialisation rights for the technology<\/strong>. The company said it is targeting completion of final trials and key regulatory milestones before <strong>March 2027<\/strong>, with commercial launch envisaged by <strong>April 2027<\/strong> \u2014 both subject to clinical outcomes and regulatory approvals. Regulatory evaluation in India is ongoing, with <strong>CDSCO approval in process<\/strong>; the company said it is also pursuing conformity requirements in Europe and <strong>FDA pathways in the US<\/strong>.<\/p>\n<p class=\"wp-block-paragraph\">Separately, the company noted it has made representations to relevant authorities seeking the technology\u2019s inclusion in <strong>national breast cancer screening programmes<\/strong>, and to <strong>IRDAI for possible insurance coverage consideration<\/strong>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>New Delhi [India], September 23: Lord\u2019s Mark Industries Limited has informed the BSE that its Technical Committee has approved the final clinical trial stage for its AI-powered, radiation-free wearable breast cancer screening device, with trials planned across the USA, Great Britain and Europe. The disclosure was made under Regulation 30 of the SEBI Listing Obligations [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":91143,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[634],"class_list":["post-91142","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-health"],"_links":{"self":[{"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/posts\/91142","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/comments?post=91142"}],"version-history":[{"count":0,"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/posts\/91142\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/media\/91143"}],"wp:attachment":[{"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/media?parent=91142"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/categories?post=91142"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newswireindia.in\/index.php\/wp-json\/wp\/v2\/tags?post=91142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}